Diplomat Names Executive Vice President of Sales, Payor Strategies
FLINT, Mich. — Oct. 30, 2017 — The nation’s largest independent provider of specialty pharmacy services has named Robyn Peters executive vice president of sales and payor strategies.
Diplomat Pharmacy, Inc. (NYSE: DPLO), has hired Robyn Peters as executive vice president of sales and payor strategies.
As a member of Diplomat’s executive leadership team, Peters will oversee payor and business development strategies, as well as sales and pharma account management.
“Continuing our focus on solutions and services for payors, we have selected a seasoned health care leader with more than 25 years of experience,” said Joel Saban, Diplomat president. “Robyn has played pivotal roles in driving business growth and developing relationships across the entire supply chain.”
Peters’ experience spans leadership roles in market access, sales, marketing, pricing, and business development. She joins Diplomat after serving as vice president of market access and reimbursement for biotechnology company Biogen, Inc. There, she expanded and led all pricing and reimbursement strategies, trade and specialty distribution, contracting, payor marketing, and account management functions.
“I look forward to meeting industry needs and opening up new opportunities for payors,” Peters said. “It is a privilege to join this talented leadership team as Diplomat continues to transform and grow in an evolving industry while consistently putting patients first.”
Before Biogen, Peters served as group vice president of managed market sales and account management for Walgreens. She oversaw all retail, specialty pharmacy, and health care sales and account management functions across managed care, health systems, and employer and government segments. Peters also held the role of vice president of U.S. payers and national accounts, corporate and government customers at biopharmaceutical company Pfizer, Inc. There, she led numerous initiatives aimed at driving innovation and growth with payor customers. Her roles have included commercial leadership positions at Boehringer Ingelheim, Schering-Plough Corporation, and MediFit Corporate Services.
Peters earned her Bachelor of Science degree from the University of Rhode Island. She serves on leadership councils for the school and as a mentor for its pharmacy program. Peters is a member of the Women Business Leaders of the U.S. Health Care Industry Foundation.
To learn more about Diplomat, visit diplomat.is.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Kali Lucas, Public Relations Specialist
810.768.9580 | email@example.com
@DiplomatRxJoin Cheryl Allen at CBI’s “Patient Journey Mapping—From Diagnosis to Treatment.” Get the latest information on pat… https://t.co/TdFgJ7IaVt2 days ago
@SpecialtyPTimes2 days ago
@SpecialtyPTimesRT @SpecialtyPTimes: Adjuvant Renal Cell Carcinoma Drug Receives FDA Greenlight https://t.co/41wVcPE8fE #Cancer #RCC2 days ago
@DiplomatRxDiplomat to Acquire LDI Integrated Pharmacy Services https://t.co/l9hgIF91i52 weeks ago
@BusLeadersforMIRT @BusLeadersforMI: VIDEO: Phil Hagerman of @DiplomatRx @SkypointFlint gets the crowd at the 2017 #MICEOSummit fired up about Flint! https…2 weeks ago